Optimal Study Design to Advance Your Therapeutic Program
TD2 is your trusted, experienced team when it comes to running preclinical oncology studies. Our extensive knowledge in both solid and hematologic tumors, immuno-oncology and adoptive cell therapy enables optimal study design and rapid study initiation.
Not only can we execute your preclinical studies, but we provide a consultative approach to ensure best results and continuity with a clinical and regulatory strategy. Our team has been involved in 600+ first in human studies. We have the specialized oncology knowledge to design and execute your preclinical program in support of your clinical and regulatory goals.
Comprehensive preclinical services.
Personalized, Expert Support
- 300+ established mouse models
- Adoptive cell therapy models
- VK*Myc mouse
- Glioblastoma PDX
- Humanized mouse models
- 400+ cancer cell lines
- Precision dosing – Tecan D300 digital dispenser
- Combination interactions with immune effector cells
- Synergy studies
- Non-GLP safety and tolerability
- Bioanalytical and DMPK capabilities
- Biomarker screening
- Optical imaging